Publication

MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    Sei-Jung Lee, Emory UniversityStefanie L. Ritter, Emory UniversityHuanchun Zhang, Emory UniversityHyunsuk Shim, Emory UniversityRandy A Hall, Emory UniversityChris Yun, Emory University
Language
  • English
Date
  • 2011-03
Publisher
  • Springer Verlag (Germany)
Publication Version
Copyright Statement
  • © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1861-9681
Volume
  • 140
Issue
  • 3
Start Page
  • 924
End Page
  • 934
Grant/Funding Information
  • This work was supported by grants from the National Institutes of Health R01DK071597 and R01DK071597-03S1 (CCY) and R01NS055179 (RAH).
  • National Institute of Diabetes and Digestive and Kidney Diseases : NIDDK
Supplemental Material (URL)
Abstract
  • SUMMARY Background & Aims Lysophosphatidic acid (LPA) is a potent inducer of colon cancer and LPA receptor type 2 (LPA2) is overexpressed in colon tumors. LPA2 interacts with membrane-associated guanylate kinase with inverted orientation-3 (MAGI-3) and the Na+/H+ exchanger regulatory factor 2 (NHERF-2), but the biological effects of these interactions are unknown. We investigated the roles of MAGI-3 and NHERF-2 in LPA2-mediated signaling in human colon cancer cells. Methods We overexpressed or knocked down MAGI-3 in HCT116 and SW480 cells. The effects of MAGI-3 and NHERF-2 in LPA-induced cell migration, invasion, inositol phosphate generation, and NF-κB activation were determined. Expression of MAGI-3 and NHERF-2 in human colon tumor tissues was analyzed using tissue microarray analysis. Results NHERF-2 promoted migration and invasion of colon cancer cells, whereas MAGI-3 inhibited these processes. MAGI-3 competed with NHERF-2 for binding to LPA2 and phospholipase C (PLC)-β3. However, NHERF-2 and MAGI-3 reciprocally regulated LPA2-induced PLC activity. MAGI-3 increased the interaction of LPA2 with Gα12, whereas NHERF-2 preferentially promoted interaction between LPA2 and Gαq. MAGI-3 decreased the tumorigenic capacity of LPA2 by attenuating the activities of NF-κB and c-Jun N-terminal kinase. MAGI-3 and NHERF-2 were differentially expressed in colon adenocarcinomas, consistent with their opposing effects. Conclusion LPA2 is dynamically regulated by 2 distinct PDZ proteins via modulation of G protein coupling and receptor signaling. MAGI-3 is a negative regulator of LPA2 signaling.
Author Notes
  • Address correspondence to: C. Chris Yun, Division of Digestive Diseases, Emory University School of Medicine, Whitehead Bldg. Room 201, 615 Michael St. Atlanta, GA 30322. Tel) 404-712-2865, ccyun@emory.edu
Keywords
Research Categories
  • Health Sciences, Oncology

Tools

Relations

In Collection:

Items